We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Mediclinic International Plc | LSE:MDC | London | Ordinary Share | GB00B8HX8Z88 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 501.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMMDC
RNS Number : 5905B
Mediclinic International PLC
17 June 2016
Mediclinic International PLC (the "Company")
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
17 June 2016
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES AND CONNECTED PERSONS
This notification is made in accordance with DTR 3.1.4(1).
Award to Mr Ian Tyler
In June 2013, the Company (then named Al Noor Hospitals Group plc) granted Mr Ian Tyler 8,695 ordinary shares (after payment of tax) in the Company, which were to be received on the third anniversary of his appointment as a director of the Company. These shares had an aggregate value of GBP50,000 at grant calculated at a share price of GBP5.75 per share. As part of the combination of Al Noor Hospitals Group plc and Mediclinic International Limited in February 2016, his award was adjusted to reflect the effect of the special dividend to the Company's shareholders paid in February 2016. The resulting award was for 12,090 ordinary shares in the Company.
On 5 June 2016, being the third anniversary of his appointment, the above award was settled through a payment of GBP106,029.30 in cash and settlement of the resulting tax liability of GBP94,026, both calculated using a share price of GBP8.77 per share. As a result of this payment, his interest under the share award has been satisfied.
The Company was informed of the above transactions in London on 14 June 2016.
Registered address: 1(st) Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
For further information, please contact:
Company Secretary - Capita Company Secretarial Services Limited
Victoria Dalby +44 (0)207 954 9600
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBXGDLSDBBGLR
(END) Dow Jones Newswires
June 17, 2016 09:30 ET (13:30 GMT)
1 Year Mediclinic Chart |
1 Month Mediclinic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
